Who Buys Etanercept from India — 64 Importers Behind a $61.4M Market
India's etanercept import market is served by 64 active buyers who collectively imported $61.4M across 251 shipments. PRESPACK JACEK KARONSKI (POLAND) leads with a 21.8% market share, followed by PRESPACK SP Z.O.O and PRESPACK JACEK KARONSKI UL SADOWA. The top 5 buyers together control 63.7% of total import value, reflecting a concentrated buyer landscape.
Top Etanercept Importers — Ranked by Import Value
PRESPACK JACEK KARONSKI (POLAND) is the leading etanercept importer from India, holding a 21.8% share of the $61.4M market across 251 shipments from 64 buyers. The top 5 buyers — PRESPACK JACEK KARONSKI (POLAND), PRESPACK SP Z.O.O (POLAND), PRESPACK JACEK KARONSKI UL SADOWA (POLAND), NICHI-IKO PHARMACEUTICAL CO LTD (JAPAN), NICHI-IKO PHARMACEUTICAL CO., LTD (JAPAN) — collectively control 63.7% of total import value.
Top Etanercept Buyers & Importers
Ranked by import value · 64 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | PRESPACK JACEK KARONSKIPOLAND ETANERCEPT AI 50MG/ML PRESPACK 11KETANERCEPT AI 50MG/ML PRESPACK 11 KETANERCEPT AUTOINJECTOR 50MG/ML PRESPACK | $13.4M | 5 | 21.8% |
| 2 | PRESPACK SP Z.O.OPOLAND ETANERCEPT AI 50MG/ML PRESPACK 11KETANERCEPT AI 50MG/ML PRESPACK 11 KETANERCEPT AUTOINJECTOR 50MG/ML PRESPACK | $8.5M | 5 | 13.9% |
| 3 | PRESPACK JACEK KARONSKI UL SADOWAPOLAND ETANERCEPT AI 50MG/ML PRESPACK 11KETANERCEPT AI 50MG/ML PRESPACK 11 KETANERCEPT AUTOINJECTOR 50MG/ML PRESPACK | $7.8M | 5 | 12.6% |
| 4 | NICHI-IKO PHARMACEUTICAL CO LTDJAPAN ETANERCEPT BS 50MG PEN 1ML SC NICHIIKOETANERCEPT BS 50MG PEN 1 ML SC NICHIIKOETANERCEPT BS 25MG SYR 0.5ML SC NICHIIKO | $5.8M | 5 | 9.4% |
| 5 | NICHI-IKO PHARMACEUTICAL CO., LTDJAPAN ETANERCEPT BS 50MG PEN 1ML SC NICHIIKOETANERCEPT BS 50MG PEN 1 ML SC NICHIIKOETANERCEPT BS 25MG SYR 0.5ML SC NICHIIKO | $3.7M | 5 | 6.0% |
| 6 | PSK PHARMARUSSIA ETANERCEPTETANERCEPT DRUG SUBSTANCEETANERCEPT DRUGS SUBSTANCE QUANTITY: | $3.0M | 5 | 4.9% |
| 7 | PSK PHARMA.,RUSSIA ETANERCEPTETANERCEPT DRUG SUBSTANCEETANERCEPT DRUGS SUBSTANCE QUANTITY: | $2.6M | 5 | 4.2% |
| 8 | NICHI-IKO PHARMACEUTICAL CO LIMITEDJAPAN ETANERCEPT BS 50MG PEN 1ML SC NICHIIKOETANERCEPT BS 50MG PEN 1 ML SC NICHIIKOETANERCEPT BS 25MG SYR 0.5ML SC NICHIIKO | $2.5M | 5 | 4.0% |
| 9 | PSK PHARMA LIMITEDRUSSIA ETANERCEPTETANERCEPT DRUG SUBSTANCEETANERCEPT DRUGS SUBSTANCE QUANTITY: | $1.7M | 5 | 2.8% |
| 10 | PRESPACK SP Z,O,OPOLAND ETANERCEPT AI 50MG/ML PRESPACK 11KETANERCEPT AI 50MG/ML PRESPACK 11 KETANERCEPT AUTOINJECTOR 50MG/ML PRESPACK | $1.7M | 5 | 2.7% |
| 11 | BOSTON ONCOLOGYSAUDI ARABIA ETANERCEPT AI 50MG/ML SAUDI, ETANERCEPTAI 50MG/ML SAUDI ,ETANERCEPT AI 50MG/ML SAUDI ETANERCEPT AI 50MG/ML SAUDI , | $1.5M | 5 | 2.5% |
| 12 | LUPIN PHARMA CANADA LIMITED,CANADA RYMTI AUTO INJECTOR 50MG/ML INJECTION 50MG/ML)RYMTI INJECTION 50MG/1ML PFS INJECTION 50MG/ML) | $1.5M | 5 | 2.4% |
| 13 | PRESPACK SP ZOOPOLAND ETANERCEPT AI 50MG/ML PRESPACK 11KETANERCEPT AI 50MG/ML PRESPACK 11 KETANERCEPT AUTOINJECTOR 50MG/ML PRESPACK | $1.2M | 5 | 2.0% |
| 14 | NICHI IKO PHARMACEUTICAL CO LTDJAPAN ETANERCEPT BS 50MG PEN 1ML SC NICHIIKOETANERCEPT BS 50MG PEN 1 ML SC NICHIIKOETANERCEPT BS 25MG SYR 0.5ML SC NICHIIKO | $1.1M | 5 | 1.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Etanercept — and from which countries?
Flow of Etanercept exports from India: each country's share and the named importers behind the numbers
Etanercept — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Poland
Poland emerges as the first largest importing country, achieving a total trade value of $33.8M through 53 shipments. This represents a market share of 55.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Poland has a diverse importer base, with their top importers including:
• PRESPACK JACEK KARONSKI - $13.4M (39.6% of country's total business)
• PRESPACK SP Z.O.O - $8.5M (25.3% of country's total business)
• PRESPACK JACEK KARONSKI UL SADOWA - $7.8M (23.0% of country's total business)
• PRESPACK SP Z,O,O - $1.7M (4.9% of country's total business)
• PRESPACK SP ZOO - $1.2M (3.6% of country's total business)
• Rest of Poland's importers - $1.2M (3.6% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $637.1K, indicating premium pricing strategy compared to the market average of $244.5K.
Poland is a key market for Etanercept imports, representing 55.0% of total trade value.
2Japan
Japan emerges as the second largest importing country, achieving a total trade value of $13.6M through 53 shipments. This represents a market share of 22.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Japan has a diverse importer base, with their top importers including:
• NICHI-IKO PHARMACEUTICAL CO LTD - $5.8M (42.5% of country's total business)
• NICHI-IKO PHARMACEUTICAL CO., LTD - $3.7M (27.0% of country's total business)
• NICHI-IKO PHARMACEUTICAL CO LIMITED - $2.5M (18.2% of country's total business)
• NICHI IKO PHARMACEUTICAL CO LTD - $1.1M (8.4% of country's total business)
Key Insight: Japan demonstrates strong market positioning with an average shipment value of $256.4K, indicating premium pricing strategy compared to the market average of $244.5K.
Japan is a key market for Etanercept imports, representing 22.1% of total trade value.
3Russia
Russia emerges as the third largest importing country, achieving a total trade value of $7.4M through 10 shipments. This represents a market share of 12.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• PSK PHARMA - $3.0M (41.2% of country's total business)
• PSK PHARMA., - $2.6M (34.7% of country's total business)
• PSK PHARMA LIMITED - $1.7M (23.2% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $736.2K, indicating premium pricing strategy compared to the market average of $244.5K.
Russia is a key market for Etanercept imports, representing 12.0% of total trade value.
4Venezuela
Venezuela emerges as the fourth largest importing country, achieving a total trade value of $2.5M through 0 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $2.5M, indicating premium pricing strategy compared to the market average of $244.5K.
Venezuela is a key market for Etanercept imports, representing 4.1% of total trade value.
5Saudi Arabia
Saudi Arabia emerges as the fifth largest importing country, achieving a total trade value of $1.5M through 4 shipments. This represents a market share of 2.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• BOSTON ONCOLOGY - $1.5M (100.0% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $384.7K, indicating premium pricing strategy compared to the market average of $244.5K.
Saudi Arabia is a key market for Etanercept imports, representing 2.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Etanercept buyer market intelligence
1Buyer Segment Analysis
The importation of Etanercept from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like PRESPACK JACEK KARONSKI and PRESPACK SP Z.O.O in Poland function as intermediaries, procuring Etanercept in bulk and supplying it to healthcare providers. Their substantial purchase volumes, totaling approximately $31.33 million, indicate a robust distribution network.
- Pharmaceutical Companies: NICHI-IKO PHARMACEUTICAL CO., LTD in Japan, with purchases amounting to $11.91 million, likely imports Etanercept for domestic distribution or further manufacturing processes.
- Government Procurement Agencies: Entities such as PSK PHARMA in Russia, accounting for $7.3 million in imports, may be involved in government tenders, supplying Etanercept to public healthcare institutions.
These segments exhibit varied order patterns: distributors often place large, regular orders to maintain supply chains; pharmaceutical companies may order based on production schedules; and government agencies typically procure through tender-based systems, leading to periodic, high-volume purchases.
Country-Specific Import Regulations
TransData Nexus Etanercept buyer market intelligence
1Country-Specific Import Regulations
Poland
1. Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 210 days for standard applications.
4. Import Tariff/Duty: Medicinal products under HS Code 30021400 are generally exempt from import duties within the EU.
Japan
1. Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
2. Import Registration Process: Involves submission of a New Drug Application (NDA) with comprehensive clinical data.
3. Estimated Timeline: Typically 12 months, depending on the product's complexity.
4. Import Tariff/Duty: Pharmaceuticals are generally subject to a 0% import duty.
Russia
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Requires state registration, including submission of quality, preclinical, and clinical data.
3. Estimated Timeline: Approximately 210 working days.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30021400 are typically subject to a 5% import duty.
Venezuela
1. Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).
2. Import Registration Process: Involves submission of a sanitary registration application with required documentation.
3. Estimated Timeline: Approximately 6 to 12 months.
4. Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties.
Saudi Arabia
1. Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality and clinical data.
3. Estimated Timeline: Approximately 12 months.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 5% import duty.
Demand Drivers & Market Opportunity
TransData Nexus Etanercept buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Etanercept in importing countries is primarily driven by the prevalence of autoimmune diseases such as rheumatoid arthritis and psoriasis. For instance, in Poland, rheumatoid arthritis affects approximately 0.9% of the population, necessitating effective treatments like Etanercept.
Government healthcare programs and the expansion of universal health coverage also play significant roles. Countries like Japan and Saudi Arabia have implemented comprehensive healthcare systems that subsidize biologic therapies, increasing patient access. Additionally, the inclusion of Etanercept in the WHO Essential Medicines List facilitates its procurement through international tenders, enhancing availability in markets like Venezuela and Russia. Our data indicates that 64 buyers across 29 countries have imported Etanercept from India, reflecting a broad and growing market opportunity.
Common Questions — Etanercept Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest etanercept buyer importing from India?
Based on import volume and value, PRESPACK JACEK KARONSKI (POLAND) leads with $13.4M in imports and a 21.8% market share — the highest of any single etanercept importer. PRESPACK SP Z.O.O (POLAND) and PRESPACK JACEK KARONSKI UL SADOWA (POLAND) are the next largest buyers.
QHow many companies buy etanercept from India?
There are 64 active etanercept buyers importing from India, with a combined market of $61.4M across 251 shipments to 29 countries. The top 5 buyers hold 63.7% of total import value, while the remaining 59 buyers handle the other 36.3%.
QWhich countries import the most etanercept from India?
The top importing countries for etanercept from India are Poland (55.0%), Japan (22.1%), Russia (12.0%), Venezuela (4.1%), Saudi Arabia (2.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of etanercept, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for etanercept from India?
The average import transaction value for etanercept from India is $244.5K, with an average unit price of $1094.98 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Etanercept buyer market intelligence
1Buyer Segment Analysis
The importation of Etanercept from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like PRESPACK JACEK KARONSKI and PRESPACK SP Z.O.O in Poland function as intermediaries, procuring Etanercept in bulk and supplying it to healthcare providers. Their substantial purchase volumes, totaling approximately $31.33 million, indicate a robust distribution network.
- Pharmaceutical Companies: NICHI-IKO PHARMACEUTICAL CO., LTD in Japan, with purchases amounting to $11.91 million, likely imports Etanercept for domestic distribution or further manufacturing processes.
- Government Procurement Agencies: Entities such as PSK PHARMA in Russia, accounting for $7.3 million in imports, may be involved in government tenders, supplying Etanercept to public healthcare institutions.
These segments exhibit varied order patterns: distributors often place large, regular orders to maintain supply chains; pharmaceutical companies may order based on production schedules; and government agencies typically procure through tender-based systems, leading to periodic, high-volume purchases.
Country-Specific Import Regulations
TransData Nexus Etanercept buyer market intelligence
1Country-Specific Import Regulations
Poland
1. Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 210 days for standard applications.
4. Import Tariff/Duty: Medicinal products under HS Code 30021400 are generally exempt from import duties within the EU.
Japan
1. Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
2. Import Registration Process: Involves submission of a New Drug Application (NDA) with comprehensive clinical data.
3. Estimated Timeline: Typically 12 months, depending on the product's complexity.
4. Import Tariff/Duty: Pharmaceuticals are generally subject to a 0% import duty.
Russia
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Requires state registration, including submission of quality, preclinical, and clinical data.
3. Estimated Timeline: Approximately 210 working days.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30021400 are typically subject to a 5% import duty.
Venezuela
1. Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).
2. Import Registration Process: Involves submission of a sanitary registration application with required documentation.
3. Estimated Timeline: Approximately 6 to 12 months.
4. Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties.
Saudi Arabia
1. Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality and clinical data.
3. Estimated Timeline: Approximately 12 months.
4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 5% import duty.
Demand Drivers & Market Opportunity
TransData Nexus Etanercept buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Etanercept in importing countries is primarily driven by the prevalence of autoimmune diseases such as rheumatoid arthritis and psoriasis. For instance, in Poland, rheumatoid arthritis affects approximately 0.9% of the population, necessitating effective treatments like Etanercept.
Government healthcare programs and the expansion of universal health coverage also play significant roles. Countries like Japan and Saudi Arabia have implemented comprehensive healthcare systems that subsidize biologic therapies, increasing patient access. Additionally, the inclusion of Etanercept in the WHO Essential Medicines List facilitates its procurement through international tenders, enhancing availability in markets like Venezuela and Russia. Our data indicates that 64 buyers across 29 countries have imported Etanercept from India, reflecting a broad and growing market opportunity.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 64 global importers of Etanercept identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 251 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 29 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
251 Verified Shipments
64 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists